A 72-year-old man with nonhealing facial erosions and bullae
Main Authors: | Catherina X. Pan, BA, Catherine E. Pisano, MD, Mia S. DeSimone, MD, MPH, Vinod E. Nambudiri, MD, MBA |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-09-01
|
Series: | JAAD Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352512622002879 |
Similar Items
-
Clinicoepidemiological Features of 82 Cases of Bullous Pemphigoid in Tehran, Iran
by: Kamran Balighi, et al.
Published: (2018-11-01) -
Regression of cutaneous squamous cell carcinoma after the development of pembrolizumab‐induced bullous pemphigoid
by: Shin Iinuma, et al.
Published: (2023-03-01) -
Case Report: A Presentation of Early-Onset Immune-Mediated Bullous Pemphigoid in a Patient with Urothelial Cancer
by: Josep Sabaté Ortega, et al.
Published: (2023-08-01) -
Successful reintroduction and continuation of nivolumab in a patient with immune checkpoint inhibitor-induced bullous pemphigoid
by: Maria L. Mihailescu, et al.
Published: (2020-12-01) -
A case report of steroid-refractory bullous pemphigoid induced by immune checkpoint inhibitor therapy
by: Shasha Guan, et al.
Published: (2023-01-01)